|
DEPARTMENT OF NEUROLOGY IN THE NEWS: 2012
 
Dr. Edward Huey Jill Goldman, MS, MPhilTHE NEW YORK TIMES
Frontotemporal Dementia (FTD) is a group of poorly-understood, frequently misdiagnosed brain diseases that can result in drastic personality changes in affected individuals. Columbia Neurology FTD expert Dr. Edward Huey and Genetic Counselor Jill Goldman were recently featured in an in-depth New York Times article titled, "When Illness Makes A Spouse A Stranger," which chronicles one couple's courageous battle with this devastating neurological disorder.
Dr. Nikolaos ScarmeasTHE NEW YORK TIMES
A new study by Dr. Nikolaos Scarmeas has found that consumption of omega-3 fatty acids, plentiful in fish and nuts, is associated with lower blood levels of beta-amyloid protein… read more in The New York Times.
Also covered by HUFFINGTON POST
Dr. Roy N. AlcalayU.S. NEWS & WORLD REPORT/HEALTHDAY
Experimental Gel May Help Those With Advanced Parkinson's
by Denise Mann
April 18, 2012
[read more]
Dr. Lawrence HonigNEW YORK TIMES
Dr. Larry Honig authored a review, currently available online in Archives of Neurology, that discusses the application of translational research to both diagnosis and treatment of dementia disorders.
Dr. Oliver SacksALIVE INSIDE
Dr. Oliver Sacks is involved in a new documentary titled, Alive Inside, featured in TIME online, which chronicles the "awakening" certain people suffering from Alzheimer's and memory loss experience when presented with music that is meaningful to them. Alive Inside premieres at the Rubin Museum of Art on Wednesday, April 18, with a series of post-screening discussions featuring AD experts Drs. Scott Small (April 18) and Ottavio Arancio (April 20), among others.
Dr. Roy N. AlcalayPARKINSON'S DISEASE
Dr. Roy Alcalay was featured in several news reports this week, commenting on a recent study that found newer antidepressants help treat depression in Parkinson's disease (PD) patients without worsening PD symptoms. Dr. Alcalay also spoke with CBS News about another study linking berry consumption with lower risk of Parkinson's disease.
Dr. Derryl C. De VivoABC NEWS
Dr. Darryl C. De Vivo spoke with ABC News this week about the nature of Spinal Muscular Atrophy (SMA), as part of a tragic story of how this rare, devastating genetic disorder can sometimes be mistaken for child abuse by untrained professionals.
[read more]
Dr. Salvatore DiMauroNIH WEDNESDAY AFTERNOON LECTURE SERIES (WALS)
Dr. DiMauro was the featured speaker at the prestigious NIH Wednesday Afternoon Lecture Series (WALS) this week. View Dr. DiMauro's lecture online: Mitochondrial DNA: Prometheus' Gift or Pandora's Box?
 
Dr. Roy Alcalay Dr. Karen Marder Dr. Elise Caccappolo Van Vliet
Drs. Roy Alcalay, Karen Marder, Elise Caccappolo and colleagues examined the neuropsychological profiles of glucocerebrosidase (GBA) mutation carriers with early-onset Parkinson's disease (PD) in participants from the Consortium on Risk for Early Onset PD Study (CORE-PD). Their results, published online this week in Neurology, showed that GBA mutation status may be an independent risk factor for cognitive impairment in patients with PD.
 
Dr. Joshua Willey Dr. Mitchell S. V. Elkind
Dr. Scott A. SmallJOURNAL OF ALZHEIMER'S DISEASE
Dr. Scott Small and colleagues from Neurology and the Taub Institute examined the association of depressive symptoms, antidepressant use and brain volumes on MRI, in a large cohort of nondemented, elderly individuals from the Washington/Hamilton Heights-Inwood Columbia Aging Project (WHICAP). Their results, currently published online in the Journal of Alzheimer's Disease, suggest that late life depression is associated with more global brain atrophy, more atrophy of the hippocampus, and more white matter lesions, mainly driven by antidepressant use.
[read more]
Dr. Karen MarderNEUROLOGY
Dr. Karen Marder co-authored a study, published in the March 6th edition of Neurology, that has dismissed a significant role for the normal allele CAG repeat length in modifying age at onset of motor manifestations in Huntington's disease. These findings indicate that the expanded allele CAG repeat length is not only the initial trigger of HD pathogenesis but also the predominant factor determining the rate of process that leads to motor onset.
[read more]
Dr. Derek J. ChongTHE NEW YORK TIMES
Dr. Derek Chong was featured in the New York Times this week, commenting on a recent study that suggests surgery, soon after antiepileptic drug therapy has failed, may be the best approach for patients with uncontrolled epilepsy.
[read more]
Dr. Roy N. AlcalayU.S. NEWS & WORLD REPORT
Dr. Roy Alcalay was featured in a U.S. News & World Report article this week, commenting on a recent study that found younger people using cholesterol-lowering drugs were less likely to develop Parkinson's disease.
[read more]
Dr. Eric R. KandelTHE NEW YORK TIMES
A Quest to Understand How Memory Works
by Claudia Dreifus
March 5, 2012
At 82, the Nobel Prize-winning neuroscientist Dr. Eric R. Kandel is still constantly coming up with new ideas for research. This winter, he has been working on a project that he hopes will lead to a new class of drugs for treating schizophrenia. [read more]
CBS New York
Eye On New York: Sleeping Pills
Dr. Derek Chong speaks with CBS 2's Dana Tyler about sleeping pill use.
March 4, 2012
Dr. Mitchell S. V. Elkind
Covered by BOSTON GLOBE, MARKETWATCH.COM, and US NEWS & WORLD REPORT
CBS
New Study Finds Big Risk For Sleeping Pills
Featuring Dr. Carl W. Bazil
February 28, 2012
[read more]
Dr. Scott A. SmallNEW YORK DAILY NEWS
Alzheimer's Path Found by Columbia Researchers
by Heidi Evans
February 13, 2012
[read more]
Dr. Nikolaos Scarmeas Dr. Mitchell S. V. Elkind Dr. Bernadette Boden-Albala
Drs. Nikolaos Scarmeas, Mitchell S. V. Elkind, and Bernadette Boden-Albala co-authored a study, led by colleagues from the University of Miami, which examined the association between a Mediterranean-style diet (MeDI) and White Matter Hyperintensity Volume (WMHV) in participants from the NOMAS cohort. The results, published in the current issue of Archives of Neurology and widely-reported, link a MeDI with lower WMHV and suggest that even modest adherence to MeDI principles may be associated with reduced risk for vascular outcomes.
Dr. Roy Alcalay Dr. Nikolaos Scarmeas
Drs. Roy Alcalay, Nikolaos Scarmeas, and others from Neurology and Taub Institute found Mediterranean-style diet adherence to be associated with reduced odds for Parkinson's disease (PD). Their study, currently published in an online version of Movement Disorders, also suggests an association between higher MeDI adherence and later PD age at onset.
[read more]
Dr. Yaakov SternSHARPBRAINS.COM
Dr. Yaakov Stern discussed his thoughts and studies on "Brain Reserve, Exercise, Cognitive Training, Angry Birds, YMCA and more," on SharpBrains.com this week.
[read more]
Dr. Scott A. SmallCHARLIE ROSE
Dr. Scott Small on recent developments in Alzheimer's
February 3, 2012
[watch video]
Dr. Scott A. SmallHEALTHDAY
Mouse Study Suggests Alzheimer's Spreads Through Brain Like an Infection
by Margaret Farley Steele and Steven Reinberg
February 2, 2012
[read more]
Dr. Scott A. SmallTHE NEW YORK TIMES
Path Is Found for the Spread of Alzheimer's
by Gina Kolata
February 1, 2012
[read more]
Also covered by BOSTON GLOBE and SIDNEY MORNING HERALD
Dr. Scott A. SmallREUTERS
Study Gives New Clues on How Alzheimer's Spreads
by Julie Steenhuysen
February 1, 2012
[read more]
Also covered by FOX NEWS, MSNBC, and BALTIMORE SUN
Dr. Adam M. BrickmanVOICE OF AMERICA
Silent Strokes Tied to Memory Loss Among Older Adults
by Melinda Smith
January 31, 2012
[read more]
[watch video]
[read the article]
Also covered by USA TODAY: Silent strokes' linked to memory loss in elderly.
Dr. Dale C. Hesdorffer
[read more]
Dr. Stephan A. MayerTHE WALL STREET JOURNAL
Stricken Senator Makes Progress
by Thomas M. Burton
January 25, 2012
[read more]
Dr. John C. M. BrustCHARLIE ROSE
Charlie Rose Brain Series 2: Agnosias
January 20, 2012
[watch video]
Dr. Jennifer J. ManlyASSOCIATED PRESS
US wants effective Alzheimer's treatment by 2025
by Lauran Neergaard
January 18, 2012
[read more]
Dr. Blair FordASSOCIATED PRESS
Ali still the Greatest as he celebrates 70th
by Tim Dahlberg
January 16, 2012
[read more]
Dr. Blair FordTHE LANCET NEUROLOGY
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial
January 11, 2012
Dr. Blair Ford has been studying the effects of deep brain stimulation (DBS) in patients with advanced Parkinson's disease, as part of a controlled, multicenter trial involving 15 clinical sites nationwide. The results, published in an online version of The Lancet Neurology last week, show nearly a threefold increase in periods of effective symptom control among subjects who received DBS compared to those that did not. [read more]
Dr. Roy N. AlcalayMSNBC.com
Homicide no longer a top cause of death in U.S.
by JoNel Aleccia
January 11, 2012
[read more]
Dr. Carl W. BazilNEW YORK-PRESBYTERIAN HOSPITAL
Lost Sleep, More Risk
January 4, 2012
[read more]
Dr. Nikolaos ScarmeasTHE NATION
Foods that may help save your memory
[read more]
Also covered by NPR ONLINE: Is There Really Such A Thing As Brain Food?
|
